Table 1.
Laboratory findings
| WBC | 5920 | × 103/μl | TP | 7.4 | g/dL |
| RBC | 389 | × 106/μl | Alb | 2.8 | g/dL |
| Hb | 13.1 | g/dL | TSH | 34.89 | μIU/mL |
| Ht | 38.9 | % | FT4 | 0.9 | ng/dL |
| PLT | 14.2 | × 104/μl | FT3 | 1.5 | pg/mL |
| PT | 56 | % | AFP | 2 | ng/mL |
| Na | 134 | meq/L | PIVKA-II | 15 | mAU/mL |
| K | 3.6 | meq/L | T-SPOT | (-) | |
| Cl | 101 | meq/L | C-ANCA | 76.2 | U/mL |
| BUN | 13 | mg/dL | P-ANCA | < 1.0 | U/mL |
| Cre | 0.49 | mg/dL | ACE | 22.9 | IU/L |
| T-Bil | 0.7 | mg/dL | Urine gravity | 1.022 | |
| AST | 57 | U/L | Hematuria | (-) | |
| ALT | 30 | U/L | Proteinuria | ( ±) | |
| Glu | 114 | mg/dL | |||
| CRP | 1.94 | mg/dL |
ANCA, anti-neutrophil cytoplasmic antibodies; ACE, angiotensin-converting enzyme